期刊文献+

维生素D定量在心血管疾病诊断中的应用

The application of Vitamin D quantitative in the diagnosis of cardiovascular disease
下载PDF
导出
摘要 目的:探讨维生素D定量在心血管疾病诊断中的作用。方法:随机选取我院2009年3月至2013年4月收入的心血管疾病患者110例为研究对象,作为观察组,另取110例健康人为对照组,分别对两组血清25-羟基维生素D [25(OH) D]进行定量检测。结果:观察组患者血清25(OH)D的浓度≥30ng/ml的仅有7例,而对照组有101例,两组相比差异显著[χ^2=160.05;P〈0.01];观察组中急性心肌梗死、不稳定性心绞痛、稳定性心绞痛、其他冠心病、心衰患者的血清25(OH) D定量结果比较无明显差异,无统计学意义(P〉0.05);与对照组比较均明显较低,有统计学意义[t=19.75;P〈0.05]。结论:血清维生素D的浓度与心血管疾病的发生、发展呈负相关,临床可通过定量检测血清维生素D对心血管疾病进行辅助诊断。 Objective:To explore the role of Vitamin D in the diagnosis of cardiovascular disease. Methods:We randomly chose 110 patients as the observation group from those who received their treatment for cardiovascular disease in our hospital from March, 2009 to April, 2013, and we chose 110 healthy people as the control group. Then we detected quantitatively 25 (OH) D in each group.Results:In the observation group, only 7 cases 25 (OH) D are with over 30ng/ml while, 101 cases are with that level in the control group . There exists a great disparity between them (χ^2=160.05;P〈0.01). In the observation group, the quantitative valueof 25 (OH) D of patients with the acute myocardial infarction, unstable angina, stable angina, other coronary heart diseases and congestive heart failure remain no obvious diferences and are of no statistic significance (P〉0.05). In contrast, the quantitative valueof 25(OH) D in the control group are much higher and are of great statistic significance (t=19.75;P〈0.05). Conclusions:There is a stro ng negative correlation between the concentration of vitamin D in the serum and the occurrence and progress of cardiovascular disease. Clinically, the quantitative testing of the vitamin D could be adopted to diagnose the cardiovascular disease.
出处 《医学检验与临床》 2015年第2期20-21,76,共3页 Medical Laboratory Science and Clinics
关键词 25-羟基维生素D 心血管疾病 诊断 25 (OH) D Cardiovascular disease Diagnosis
  • 相关文献

参考文献9

  • 1李敏,于慧会,时景璞.25羟维生素D水平与心血管疾病关系的Meta分析[J].中华疾病控制杂志,2011,15(11):939-942. 被引量:20
  • 2刘隆健,魏敏,陈明,Shelley R Hankins,Ana E.Nùez,Robert A Watson,Perry J Weinstock,Craig J.Newschaffer,Howard J Eisen,邹强,杨书,陈卫中.心血管疾病病死率与血清25-羟基维生素D浓度相关性研究[J].成都医学院学报,2013,8(2):131-134. 被引量:6
  • 3Andreas Tomaschitz,Eberhard Ritz,Burkert Pieske,et al.Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease[J]. Metabolism,, 2014, 63 ( 1 ) : 20-31.
  • 4Marai I, Massalha S. Effect of omega-3 polyunsaturated fatty acids and vitamin D on cardiovascular diseases [J].Isr MedAssocJ, 2014, 16 (2): 117-121.
  • 5Sezer S, Tutal E, Bal Z, Uyar ME, Haberal M, et al.Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients[J].IntJ ArtifOrgans, 2014, 2 ( 37 ) : 118-125.
  • 6William B. Grant, Alan N. Peiris.Possible Role of Serum 25-Hydroxyvitamin D in Black - White Health Disparities in the United States[J].Journal of the American Medical Directors Association, 2010,11 ( 9 ) : 617-628.
  • 7Vincent M. Brandenburg, Marc G. Vervloet, Nikohus Marx.The role of vitamin D in cardiovascular disease: From present evidence to future perspectives[J].Athemsclerosis, 2012,225 ( 2 ) : 253-263.
  • 8JoAnn E.Manson,Shari S.Bassuk,I-Min Lee,et al.The VITamin D and OmegA-3 Trial (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease[J]. Contemporary Clinical Trials, 2012,33 ( 1 ) : 159-171.
  • 9Heidi T. May, Tami L. Bair, Donald L. Lapp, et al. Anderson, et aL.Association of vitamin D levels with incident depression among a general cardiovascular population[J]. American Heart Jouma, 2010,159 (6) : 1037-1043.

二级参考文献28

  • 1Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics: 2009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J]. Circulation, 2009,119 (3) : 480-486.
  • 2I.iu I.,Nettleton JA, Bertoni AG, et al. Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic s[J]. The :362-368.
  • 3Centers for Disease Control and Prevention, National Center for Health Statistics. 1988-1994 National Health and Nutrition Examination Survey Data[EB/OL]. http://www, cdc. gov/ nehs/surveys, html,2010-04-16/2013-04/07.
  • 4Holick MF. Vitamin D status : measurement, interpretation, and clinical application[J]. Annals of Epidemiology, 2009,19 ( 2 ):73-78.
  • 5Shrestha LB. I.ife expectancy in the United States[EB/OL]. http://www, aging, senate, gov/crs/agingl, pdf, 2006-08-16/ 2013-04-07.
  • 6SAS Institute. SAS/STAT User's Guide, Version 9. 1 [M]. Cary, NC : SAS Institute, 2005 : 3884.
  • 7Mursu l, Rohien K, Haraack LJ ,et al. Dietary supplements and mortality rate in older women: the Iowa women's health study [J]. Archives of Internal Medicine,2011,171 (18) :1625-1633.
  • 8Marniemi J,Alanen E,Impivaara O,et al.Dietary and serumvitamins and minerals as predictors of myocardial infarction andstroke in elderly subjects. Nutrition Metabolism and Cardiovascular Diseases . 2005
  • 9Schleithoff SS,Zittermann A,Stuttgen B,et al.Low serumlevels of intact osteocalcin in patients with congestive heart fail-ure. Journal of Bone and Mineral Metabolism . 2003
  • 10Alsafwah S,Laguardia SP,Nelson MD,et al.HypovitaminosisD in African Americans residing in Memphis,Tennessee withand without heart failure. The American Journal of The Medical Sciences . 2008

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部